Translating pharmacogenomics: Challenges on the road to the clinic

Citations of this article
Mendeley users who have this article in their library.


Pharmacogenomics is one of the first clinical applications of the postgenomic era. It promises personalized medicine rather than the established "one size fits all" approach to drugs and dosages. The expected reduction in trial and error should ultimately lead to more efficient and safer drug therapy. In recent years, commercially available pharmacogenomic tests have been approved by the Food and Drug Administration (FDA), but their application in patient care remains very limited. More generally, the implementation of pharmacogenomics in routine clinical practice presents significant challenges. This article presents specific clinical examples of such challenges and discusses how obstacles to implementation of pharmacogenomic testing can be addressed. © 2007 Swen et al.




Swen, J. J., Huizinga, T. W., Gelderblom, H., De Vries, E. G. E., Assendelft, W. J. J., Kirchheiner, J., & Guchelaar, H. J. (2007, August). Translating pharmacogenomics: Challenges on the road to the clinic. PLoS Medicine.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free